We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Double Helix Technologies teams-up with Agilent Technologies
News

Double Helix Technologies teams-up with Agilent Technologies

Double Helix Technologies teams-up with Agilent Technologies
News

Double Helix Technologies teams-up with Agilent Technologies

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Double Helix Technologies teams-up with Agilent Technologies"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Double Helix Technologies (Doulix) has announced a collaboration with Agilent Technologies Inc. to promote Agilent's SureVector next-generation cloning kits through Doulix’s web platform. Through this partnership, synthetic biologists will be able to choose among SureVector’s standard DNA parts to design custom plasmids using Doulix’s web platform.

Agilent’s SureVector is the latest innovation in next-generation cloning. SureVector harnesses the power of synthetic biology by allowing the combination of standard validated parts to create novel vector constructs. The SureVector system enables the rapid and reliable assembly of custom plasmids for mammalian, E. coli, and yeast cells by combining Agilent's functional DNA modules with custom genes and components.

Doulix is a comprehensive toolkit for synthetic biology that allows users to easily design, validate and synthesize custom DNA vectors.

Doulix combines the convenience of pre-made standard DNA parts with the freedom of a full-fledge sequence editor. Doulix also offers a validation algorithm that allows users to review their constructs for common design flaws before proceeding to synthesis.

“Today, the unmatched flexibility of SureVector and the design capability of Doulix come together to unlock the full potential of synthetic biology” said Davide De Lucrezia, Managing Director of Doulix.

“This collaboration is an exciting step forward for SureVector," said Laura Whitman, Global Synthetic Biology Product Manager for Agilent, "It allows researchers to create individual vectors and the ability to customise any fragment in the SureVector system.”

Agilent has been a leading provider of molecular biology tools since it acquired Stratagene in 2007. It is one of the few companies whose products address the entire workflow for molecular and synthetic biology, and "SureVector is part of Agilent's continued commitment to providing revolutionary tools for molecular biology", said Agilent’s Whitman.
Advertisement